Business Development Manager - Licensing

Seeking a Business Development Manager – Licensing to drive strategic licensing, out-licensing, co-development, and partnership opportunities. This role combines scientific expertise with business development to identify, evaluate, negotiate, and execute licensing transactions while collaborating with cross-functional teams.
Responsibilities

Establish external business opportunities for out-licensing, co-development, and other structured transactions.
Lead the development and presentation of business cases of prioritized external opportunities with recommendations to management team with robust analyses, key assumptions, and risks, as well as internal and external input where necessary.
Initiate, lead and present external opportunities with limited supervision.
Lead driving cross-functional due diligence and alliance management, coordinate with R&D, CMC, Clinical, Regulatory, Operations, and Finance and executive reporting, in some instances be the main BD contact person.
Follow BD operations and transactions including proposals and TS developments, negotiations, deal closure and alliance management.
Contribute to the definition and revision of business development & licensing strategy that is in line with overall corporate and portfolio strategies.
Represent Biocytogen at industry, investor and partnering conferences, develop and maintain relationships with a wide range of pharmaceutical/biotechnology industry participants.
Required Qualifications

Ph.D. in pharmacology, immunology, cancer biology, or a related biomedical science field
Strong background in antibody drug discovery, with a deep understanding of target validation and hit-to-lead optimization
Proven ability to interpret complex biological data (affinity, specificity, and in vivo efficacy) and translate it into a compelling therapeutic and licensing narrative
Familiarity with current antibody modalities, including monoclonal antibodies (mAbs), bispecific antibodies, and ADCs
Strong strategic thinking skills to align internal scientific platform capabilities with pharmaceutical partner pipeline gaps
Mandarin and English bilingual, to effectively bridge global R&D and business communications

#J-18808-Ljbffr